FDA gives nod for AstraZeneca’s Imfinzi to treat endometrial cancer
The US Food and Drug Administration has approved AstraZeneca’s combination therapy, Imfinzi, for adult patients with endometrial cancer, according to a company statement.
Drugs
Health
Pharma